Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CSE/DOSE stock hub

CSE/DOSE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

CSE/DOSEis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
14.3M
Canadian Securities Exchange
Market data

Live price

Current market quote for this ticker.

Current price
CSE/DOSE
In the news

Latest news · CSE/DOSE

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11P50 15.6P75 25.4
Trailing P/En/a
P25 7.4P50 15.6P75 34.3
ROEn/a
P25 -121.5P50 -40.9P75 0.5
ROICn/a
P25 -72.5P50 -16P75 1.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All CSE/DOSE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
167
Groups with data
11
Currency
CAD
Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
Canada
Country code
CA
Enterprise value
CAD 20M
Exchange
Canadian Securities Exchange
Financial currency
CAD
First seen
2026-05-10
Industry
Biotechnology
Isin
CA75339A1012
Last refreshed
2026-05-10
Market cap
CAD 14.3M
Price
CAD 0.11
Price currency
CAD
Sector
Healthcare
Sic
2834
Symbol
cse/DOSE
Website
https://rapid-dose.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-30.51%
EV Earnings
-4.57x
EV/FCF
-22.93x
EV/Sales
7.18x
FCF yield
-6.08%
P/B ratio
-2.16x
P/S ratio
5.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

16
MetricValue
EBIT Margin
-110.68%
EBITDA Margin
-95.17%
Gross margin
50.44%
Gross Profit
CAD 1.4M
Gross Profit Growth
46.17%
Gross Profit Growth Q
14.6%
Gross Profit Growth3 Y
75.4%
Gross Profit Growth5 Y
64.52%
Net Income
CAD -4.4M
Net Income Growth Quarters
4%
Net Income Growth Years
0%
Pretax Margin
-157.17%
Profit Margin
-157.17%
ROA
-70.49
Roa5y
-85.59
ROCE
69.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr1y
-44.76%
Cagr3y
3.39%
Cagr5y
-14.14%
EPS Growth Quarters
4
EPS Growth Years
0
Revenue Growth
72.84x
Revenue Growth Q
30.99x
Revenue Growth Quarters
7x
Revenue Growth Years
2x
Revenue Growth3 Y
62.62x
Revenue Growth5 Y
70.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Asset Turnover
CAD 1.02
Assets
CAD 3.8M
Cash
CAD 109,163
Current Assets
CAD 664,248
Current Liabilities
CAD 8.2M
Debt
CAD 5.8M
Debt FCF
CAD -6.62
Equity
CAD -6.6M
Interest Coverage
-2.38
Liabilities
CAD 10.4M
Long Term Assets
CAD 3.1M
Long Term Liabilities
CAD 2.2M
Net Cash
CAD -5.7M
Net Cash By Market Cap
CAD -39.48
Tangible Book Value
CAD -6.6M
Tangible Book Value Per Share
CAD -0.05
WACC
5.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.08
Inventory Turnover
5.88
Net Working Capital
CAD -4.1M
Quick ratio
0.04
Working Capital
CAD -7.6M
Working Capital Turnover
CAD -0.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-7.98%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-44.74%
200-day SMA
0.15
3Y total return
10.53%
50-day SMA
0.11
50-day SMA vs 200-day SMA
50under200
5Y total return
-53.33%
All Time High
1.33
All Time High Change
-92.11%
All Time High Date
2019-01-04
All Time Low
0.07
All Time Low Change
50%
All Time Low Date
2022-08-25
ATR
0.01
Beta
-0.69
Beta1y
0.84
Beta2y
0.18
Ch YTD
-19.23
High
0.11
High52
0.24
High52 Date
2025-07-09
High52ch
-56.25%
Low
0.11
Low52
0.09
Low52 Date
2026-03-24
Low52ch
16.67%
Ma50ch
-5.83%
Price vs 200-day SMA
-31.99%
RSI
48.09
RSI Monthly
38.76
RSI Weekly
37.39
Sharpe ratio
-0.09x
Sortino ratio
-0.07
Total Return
-7.98%
Tr YTD
-19.23
Tr1m
-8.7%
Tr1w
5%
Tr3m
-27.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
CAD -3.1M
Operating margin
-110.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
115,793,410%
Net Borrowing
3,085,304
Shares Insiders
15.14%
Shares Out
136,444,838
Shares Qo Q
59.51%
Shares Yo Y
7.98%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

48
MetricValue
Adjusted FCF
CAD -1.5M
Average Volume
36,103.5x
Bv Per Share
-0.05
CAPEX
CAD -6,639
Ch1m
-8.7
Ch1w
5
Ch1y
-44.74
Ch3m
-27.59
Ch3y
10.53
Ch5y
-53.33
Ch6m
-30
Change
0%
Change From Open
-4.55
Close
0.11
Days Gap
4.76
Depreciation Amortization
431,547
Dollar Volume
745.5
Earnings Date
2026-06-26
EBIT
CAD -3.1M
EBITDA
CAD -2.6M
EPS
CAD -0.03
F Score
2
FCF
CAD -871,445
FCF EV Yield
-4.36x
FCF Per Share
CAD -0.01
Financing CF
3,488,383
Fiscal Year End
February
Investing CF
-2,554,513
Is Primary Listing
1
Last Earnings Date
2026-01-29
Last Report Date
2025-11-30
Ma150
0.14
Ma150ch
-25.74%
Ma20
0.11
Ma20ch
-0.76%
Net CF
69,064
Next Earnings Date
2026-06-26
Open
0.11
Position In Range
0
Ppne
3,124,427
Price Date
2026-05-08
Relative Volume
0.2x
Revenue
2,781,374x
SBC By Revenue
23.33x
Share Based Comp
648,852
Tr6m
-30%
Volume
7,100
Z Score
-20.37
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does CSE/DOSE pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/DOSE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-44.7%
S&P 500 1Y: n/a
3Y total return
+10.5%
S&P 500 3Y: n/a
5Y total return
-53.3%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns CSE/DOSE?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+15.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+8.0%
Negative means the company is buying back shares.
Technical

CSE/DOSE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
48.1
Neutral momentum band
Price vs 200-day MA
-32.0%
50/200-day relationship not available
Beta (5Y)
-0.69
Less volatile than the market
Sharpe ratio
-0.09
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About CSE/DOSE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/DOSE stock rating?

cse/DOSE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/DOSE analysis?

The full report lives at /stocks/cse/DOSE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/DOSE?

The latest report frames cse/DOSE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/DOSE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

cse/DOSE stock profile: metrics, valuation and analysis | StockMarketAgent.AI